These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 22036464)

  • 1. [Treatment of psoriasis with anti-TNF drugs in human immunodeficiency virus-infected patients].
    de Unamuno-Bustos B; Ballester-Sánchez R; Pérez-Ferriols A; Sánchez Carazo JL
    Med Clin (Barc); 2012 May; 138(13):593-4. PubMed ID: 22036464
    [No Abstract]   [Full Text] [Related]  

  • 2. Efficacy and safety of subcutaneous anti-tumor necrosis factor-alpha agents, etanercept and adalimumab, in elderly patients affected by psoriasis and psoriatic arthritis: an observational long-term study.
    Esposito M; Giunta A; Mazzotta A; Zangrilli A; Babino G; Bavetta M; Perricone R; Chimenti S; Chimenti MS
    Dermatology; 2012; 225(4):312-9. PubMed ID: 23295383
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management of severe psoriasis with TNF antagonists. Adalimumab, etanercept and infliximab.
    Mössner R; Reich K
    Curr Probl Dermatol; 2009; 38():107-136. PubMed ID: 19710553
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Baseline anti-dsDNA concentrations and previous treatments predict response to Adalimumab and Etanercept: a retrospective investigation of 146 psoriasis patients.
    Hoffmann JH; Knoop C; Enk AH; Hadaschik EN
    J Dermatol Sci; 2014 Dec; 76(3):180-5. PubMed ID: 25306295
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Treatment of moderate-severe psoriasis with etanercept in patients with chronic human immunodeficiency virus infection].
    Barco D; Puig L; Alomar A
    Actas Dermosifiliogr; 2010 May; 101 Suppl 1():77-81. PubMed ID: 20492885
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of drug survival rates for adalimumab, etanercept and infliximab in patients with psoriasis vulgaris.
    Gniadecki R; Kragballe K; Dam TN; Skov L
    Br J Dermatol; 2011 May; 164(5):1091-6. PubMed ID: 21219290
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Survival rate of antitumour necrosis factor-α treatments for psoriasis in routine dermatological practice: a multicentre observational study.
    Esposito M; Gisondi P; Cassano N; Ferrucci G; Del Giglio M; Loconsole F; Giunta A; Vena GA; Chimenti S; Girolomoni G
    Br J Dermatol; 2013 Sep; 169(3):666-72. PubMed ID: 23647206
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Switching to adalimumab in patients with moderate to severe psoriasis who have failed on etanercept: a retrospective case cohort study.
    Woolf RT; Smith CH; Robertson K; Barker JN
    Br J Dermatol; 2010 Oct; 163(4):889-92. PubMed ID: 20854408
    [No Abstract]   [Full Text] [Related]  

  • 9. Genetic markers of treatment response to tumour necrosis factor-α inhibitors in the treatment of psoriasis.
    Ryan C; Kelleher J; Fagan MF; Rogers S; Collins P; Barker JN; Allen M; Hagan R; Renfro L; Kirby B
    Clin Exp Dermatol; 2014 Jun; 39(4):519-24. PubMed ID: 24758522
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sustained efficacy and safety of adalimumab in psoriasis treatment: a retrospective study of 49 patients with and without a history of TNF-alpha antagonist treatment.
    Van L; Modi SV; Yang DJ; Hsu S
    Arch Dermatol; 2008 Jun; 144(6):804-6. PubMed ID: 18559778
    [No Abstract]   [Full Text] [Related]  

  • 11. Tumour necrosis factor-α antagonists in patients with concurrent psoriasis and hepatitis B or hepatitis C: a retrospective analysis of 17 patients.
    Prignano F; Ricceri F; Pescitelli L; Zanieri F; Lotti T
    Br J Dermatol; 2011 Mar; 164(3):645-7. PubMed ID: 21375517
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Successful treatment with etanercept of von Zumbusch pustular psoriasis in a patient with human immunodeficiency virus.
    Mikhail M; Weinberg JM; Smith BL
    Arch Dermatol; 2008 Apr; 144(4):453-6. PubMed ID: 18427038
    [No Abstract]   [Full Text] [Related]  

  • 13. Psoriasis treatment patterns with etanercept and adalimumab in a United States health plan population.
    Chastek B; Fox KM; Watson C; Kricorian G; Gandra SR
    J Dermatolog Treat; 2013 Feb; 24(1):25-33. PubMed ID: 22668321
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical experience of QuantiFERON(®) -TB Gold testing in patients with psoriasis treated with tumour necrosis factor blockers in Taiwan.
    Chiu HY; Hsueh PR; Tsai TF
    Br J Dermatol; 2011 Mar; 164(3):553-9. PubMed ID: 21083541
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of MGUS in psoriatic patients: a possible undiagnosed event during anti-TNF-α-treatment.
    Prignano F; Pescitelli L; Ricceri F; Ermini A; Lotti T
    J Eur Acad Dermatol Venereol; 2012 Nov; 26(11):1444-8. PubMed ID: 21834947
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Successful use of antitumor necrosis factor-alpha biological therapy in managing human immunodeficiency virus-associated arthritis: three case studies from Saudi Arabia.
    Almoallim H; Jali I; Wali G
    Joint Bone Spine; 2013 Jul; 80(4):426-8. PubMed ID: 23453475
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical predictors of non-response to any tumor necrosis factor (TNF) blockers: a retrospective study.
    Di Lernia V; Ricci C; Lallas A; Ficarelli E
    J Dermatolog Treat; 2014 Feb; 25(1):73-4. PubMed ID: 23621374
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factors influencing seasonal patterns of relapse in anti-TNF psoriatic responders after temporary drug discontinuation.
    Ruano J; Velez A; Casas E; Rodriguez-Martin A; Salido R; Isla-Tejera B; Espejo-Alvarez J; Gómez F; Jiménez-Puya R; Moreno-Giménez JC
    J Eur Acad Dermatol Venereol; 2014 Apr; 28(4):516-8. PubMed ID: 23841941
    [No Abstract]   [Full Text] [Related]  

  • 19. Paradoxical worsening of psoriasis when switching from etanercept to adalimumab: a case series.
    Bhutani T; Koo J
    J Dermatolog Treat; 2011 Apr; 22(2):75-8. PubMed ID: 20524874
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is etanercept safe for treating plaque psoriasis in a patient with chronic hepatitis C virus infection?
    Gandhi RK; Pickup T; Sheth PB
    Arch Dermatol; 2010 Oct; 146(10):1151-2. PubMed ID: 20956650
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.